Next Article in Journal
Do Patient-Reported Outcome Measures (PROMs) Used Within Radiotherapy Clinical Trials Reflect the Impact of Treatment?
Next Article in Special Issue
68Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry
Previous Article in Journal
Are All Prognostic Stage IB Breast Cancers Equivalent?
Previous Article in Special Issue
A Study in Pituitary Neuroendocrine Tumors (PitNETs): Real-Life Data Amid Baseline and Serial CT Scans
 
 
Review

Article Versions Notes

Cancers 2024, 16(22), 3831; https://doi.org/10.3390/cancers16223831
Action Date Notes Link
article html file updated 29 June 2025 17:35 CEST Update https://www.mdpi.com/2072-6694/16/22/3831/html
article html file updated 14 November 2024 15:36 CET Original file -
article pdf uploaded. 14 November 2024 15:34 CET Version of Record https://www.mdpi.com/2072-6694/16/22/3831/pdf
article xml uploaded. 14 November 2024 15:34 CET Update https://www.mdpi.com/2072-6694/16/22/3831/xml
article xml file uploaded 14 November 2024 15:34 CET Original file -
Back to TopTop